[1]
|
Sabin, C.A., Worm, S.W., Weber, R., et al. (2008) Use of Nucleoside Reverse Transcriptase Inhibitors and Risk of Myocardial Infarction in HIV-Infected Patients Enrolled in the D: A: D Study: A Multi-Cohort Collaboration. Lancet, 371, 1417-1426. http://dx.doi.org/10.1016/S0140-6736(08)60423-7
|
[2]
|
Corral, I., Quereda, C., Moreno, A., et al. (2009) Cerebrovascular Ischemic Events in HIV-1-Infected Patients Receiving Highly Active Antiretroviral Therapy: Incidence and Risk Factors. Cerebrovascular Diseases, 27, 559-563. http://dx.doi.org/10.1159/000214219
|
[3]
|
Constans, J. and Conri, C. (2006) Circulating Markers of Endothelial Function in Cardiovascular Disease. Clinica Chimica Acta, 368, 33-47. http://dx.doi.org/10.1016/j.cca.2005.12.030
|
[4]
|
Hsue, P.Y., Lo, J.C., Franklin, A., et al. (2004) Progression of Atherosclerosis as Assessed by Carotid Intima-Media Thickness in Patients with HIV Infection. Circulation, 109, 1603-1608. http://dx.doi.org/10.1161/01.CIR.0000124480.32233.8A
|
[5]
|
Lorenz, M.W., Stephan, C., Harmjanz, A., et al. (2008) Both Long-Term HIV Infection and Highly Active Antiretroviral Therapy Are Independent Risk Factors for Early Carotid Atherosclerosis. Atherosclerosis, 196, 720-726. http://dx.doi.org/10.1016/j.atherosclerosis.2006.12.022
|
[6]
|
Glazier, J.J., Spears, J.R. and Murphy, M.C. (2006) Interventional Approach to Recurrent Myocardial Infarction in HIV-1 Infection. Journal of Interventional Cardiology, 19, 93-98. http://dx.doi.org/10.1111/j.1540-8183.2006.00111.x
|
[7]
|
Fourie, C., van Rooyen, J., Pieters, M., Conradie, K., Hoekstra, T. and Schutte, A. (2011) Is HIV-1 Infection Associated with Endothelial Dysfunction in a Population of African Ancestry in South Africa? Cardiovascular Journal of Africa, 22, 134-140. http://dx.doi.org/10.5830/CVJA-2010-056
|
[8]
|
Fisher, S.D., Miller, T.L. and Lipshultz, S.E. (2006) Impact of HIV and Highly Active Antiretroviral Therapy on Leukocyte Adhesion Molecules, Arterial Inflammation, Dyslipidemia, and Atherosclerosis. Atherosclerosis, 185, 1-11. http://dx.doi.org/10.1016/j.atherosclerosis.2005.09.025
|
[9]
|
Schillaci, G., De Socio, G.V., Pucci, G., et al. (2008) Aortic Stiffness in Untreated Adult Patients with Human Immunodeficiency Virus Infection. Hypertension, 52, 308-313. http://dx.doi.org/10.1161/HYPERTENSIONAHA.108.114660
|
[10]
|
Aberg, J.A. (2009) Cardiovascular Complications in HIV Management: Past, Present, and Future. Journal of Acquired Immune Deficiency Syndromes, 50, 54-64. http://dx.doi.org/10.1097/QAI.0b013e31818ceaa4
|
[11]
|
Feitas, P., Carvalho, D., Souto, S., et al. (2011) Impact of Lipodystrophy on the Prevalence and Components of Metabolic Syndrome in HIV-Infected Patients. BMC Infectious Diseases, 11, 246. http://dx.doi.org/10.1186/1471-2334-11-246
|
[12]
|
Lakka, H.M., Laaksonen, D.E., Lakka, T.A., et al. (2002) The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-Aged Men. Journal of the American Medical Association, 288, 2709-2716. http://dx.doi.org/10.1001/jama.288.21.2709
|
[13]
|
Hansen, T.W., Staessen, J.A., Torp-Pedersen, C., et al. (2006) Prognostic Value of Aortic Pulse Wave Velocity as Index of Arterial Stiffness in the General Population. Circulation, 113, 664-670. http://dx.doi.org/10.1161/CIRCULATIONAHA.105.579342
|
[14]
|
Lekakis, J., Ikonomidis, I., Palios, J., et al. (2009) Association of Highly Active Antiretroviral Therapy with Increased Arterial Stiffness in Patients Infected with Human Immunodeficiency Virus. American Journal of Hypertension, 22, 828-834. http://dx.doi.org/10.1038/ajh.2009.90
|
[15]
|
Joint United Nations Programme on HIV/AIDS (UNAIDS) (2008) Report on the Global HIV/AIDS Epidemic. Geneva. http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/2008_Global_report.asp
|
[16]
|
Mancia, G., De Backer, G., Dominiczak, A., et al. (2007) 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension, 25, 1105-1187. http://dx.doi.org/10.1097/HJH.0b013e3281fc975a
|
[17]
|
Grundy, S.M., Cleeman, J.I., Daniels, S.R., et al. (2005) Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112, 2735-2752. http://dx.doi.org/10.1161/CIRCULATIONAHA.105.169404
|
[18]
|
Hermans, M.P., Ahn, S.A. and Rousseau, M.F. (2010) log (TG)/HDL-C Is Related to Both Residual Cardiometabolic Risk and β-Cell Function Loss In type 2 Diabetes Males. Cardiovascular Diabetology, 9, 88. http://dx.doi.org/10.1186/1475-2840-9-88
|
[19]
|
Asmar, R., Benetos, A., Topouchian, J., et al. (1995) Assessment of Arterial Distensibility by Automatic Pulse Wave Velocity Measurement. Validation and Clinical Application Studies. Hypertension, 26, 485-490. http://dx.doi.org/10.1161/01.HYP.26.3.485
|
[20]
|
Lemogoum, D., Van Bortel, L., Najem, B., et al. (2004) Arterial Stiffness and Wave Reflections in Patients with Sickle Cell Disease. Hypertension, 44, 924-929. http://dx.doi.org/10.1161/01.HYP.0000148506.73622.ba
|
[21]
|
Twagirumukiza, M., De Bacquer, D., Kips, J., de Backer, G., Vander Stichele, R. and Van Bortel, L. (2011) Current and Projected Prevalence of Arterial Hypertension in Sub-Saharan Africa by Sex, Age and Habitat: An Estimate from Population Studies. Journal of Hypertension, 29, 1243-1252. http://dx.doi.org/10.1097/HJH.0b013e328346995d
|
[22]
|
Palacios, R., Santos, J., García, A., Castells, E., González, M., Ruiz, J. and Márquez, M. (2006) Impact of Highly Active Antiretroviral Therapy on Blood Pressure in HIV-Infected Patients. A Prospective Study in a Cohort of Naive Patients. HIV Medicine, 7, 10-15. http://dx.doi.org/10.1111/j.1468-1293.2005.00333.x
|
[23]
|
Bloomfield, G.S., Hogan, J.W., Keter, A., Sang, E., Carter, E.J., Velazquez, E.J. and Kimaiyo, S. (2011) Hypertension and Obesity as Cardiovascular Risk Factors among HIV Seropositive Patients in Western Kenya. PloS ONE, 6, Article ID: e22288. http://dx.doi.org/10.1371/journal.pone.0022288
|
[24]
|
He, F.J. and MacGregor, G.A. (2009) A Comprehensive Review on Salt and Health and Current Experience of Worldwide Salt Reduction Programmes. Journal of Human Hypertension, 23, 363-384. http://dx.doi.org/10.1038/jhh.2008.144
|
[25]
|
He, F.J., Marciniak, M., Visagie, E., Markandu, N.D., Anand, V., Dalton, R.N. and MacGregor, G.A. (2009) Effect of Modest Salt Reduction on Blood Pressure, Urinary Albumin, and Pulse Wave Velocity in White, Black, and Asian Mild Hypertensives. Hypertension, 54, 482-488. http://dx.doi.org/10.1161/HYPERTENSIONAHA.109.133223
|
[26]
|
Yoshida, M., Mita, T., Yamamoto, R., Shimizu, T., Ikeda, F., Ohmura, C., Kanazawa, A., Hirose, T., Kawamori, R. and Watada, H. (2012) The Combination of Framingham Risk Score and Carotid Intima-Media Thickness Improves the Prediction of Cardiovascular Events in Patients with Type 2 Diabetes. Diabetes Care, 35, 178-180. http://dx.doi.org/10.2337/dc11-1333
|
[27]
|
Brown, T.T., Cole, S.R., Li, X., Kingsley, L.A., Palella, F.J., Riddler, S.A., Visscher, B.R., Margolick, J.B. and Dobs, A.S. (2005) Antiretroviral Therapy and the Prevalence and Incidence of Diabetes Mellitus in the Multicenter AIDS Cohort Study. JAMA Internal Medicine, 165, 1179-1184. http://dx.doi.org/10.1001/archinte.165.10.1179
|
[28]
|
Capeau, J., Bouteloup, V., Katlama, C., et al. (2012) Ten-Year Diabetes Incidence in 1046 HIV-Infected Patients Started on a Combination Antiretroviral Treatment: The ANRS CO8 APROCO-COPILOTE Cohort. AIDS, 26, 303-314. http://dx.doi.org/10.1097/QAD.0b013e32834e8776
|
[29]
|
Mineo, C., Deguchi, H., Griffin, J.H. and Shaul, P.W. (2006) Endothelial and Antithrombotic Actions of HDL. Circulation Research, 98, 1352-1364. http://dx.doi.org/10.1161/01.RES.0000225982.01988.93
|
[30]
|
Patel, S., Puranik, R., Nakhla, S., Lundman, P., Stocker, R., Wang, X.S., Lambert, G., Rye, K.A., Barter, P.J., Nicholls, S.J. and Celermajer, D.S. (2009) Acute Hypertriglyceridaemia in Humans Increases the Triglyceride Content and Decreases the Anti-Inflammatory Capacity of High Density Lipoproteins. Atherosclerosis, 204, 424-428. http://dx.doi.org/10.1016/j.atherosclerosis.2008.07.047
|
[31]
|
Cziraky, M.J., Watson, K.E. and Talbert, R.L. (2008) Targeting Low HDL-Cholesterol to Decrease Residual Cardiovascular Risk in the Managed Care Setting. Journal of Managed Care Pharmacy, 14, S3-S28.
|
[32]
|
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.R. and Groop, L. (2001) Cardiovascular Morbidity and Mortality Associated with the Metabolic Syndrome. Diabetes Care, 24, 683-689. http://dx.doi.org/10.2337/diacare.24.4.683
|
[33]
|
Greenwald, S., Carter, A. and Berry, C. (1990) Effect of Age on the in Vitro Reflection Coefficient of the Aortoiliac Bifurcation in Humans. Circulation, 82, 114-123. http://dx.doi.org/10.1161/01.CIR.82.1.114
|
[34]
|
Avolio, A.P., Deng, F.Q., Li, W.Q., Luo, Y.F., Huang, Z.D., Xing, L.F. and O’Rourke, M.F. (1985) Effects of Aging on Arterial Distensibility in Populations with High and Low Prevalence of Hypertension: Comparison between Urban and Rural Communities in China. Circulation, 71, 202-210. http://dx.doi.org/10.1161/01.CIR.71.2.202
|
[35]
|
van Vonderen, M.G., Smulders, Y.M., Stehouwer, C.D., et al. (2009) Carotid Intima-Media Thickness and Arterial Stiffness in HIV Infected Patients: The Role of HIV, Antiretroviral Therapy, and Lipodystrophy. Journal of Acquired Immune Deficiency Syndromes, 50, 153-161. http://dx.doi.org/10.1097/QAI.0b013e31819367cd
|
[36]
|
Zieman, S.J., Melenovsky, V. and Kass, D.A. (2005) Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 932-943. http://dx.doi.org/10.1161/01.ATV.0000160548.78317.29
|
[37]
|
McEniery, C.M. and Wilkinson, I.B. (2005) Large Artery Stiffness and Inflammation. Journal of Human Hypertension, 19, 507-509. http://dx.doi.org/10.1038/sj.jhh.1001814
|
[38]
|
Hingorani, A.D., Cross, J., Kharbanda, R.K., et al. (2000) Acute Systemic Inflammation Impairs Endothelium-Dependent Dilatation in Humans. Circulation, 102, 994-999. http://dx.doi.org/10.1161/01.CIR.102.9.994
|